VNRX
Income statement / Annual
Last year (2024), VolitionRx Limited's total revenue was $1.23 M,
an increase of 59.10% from the previous year.
In 2024, VolitionRx Limited's net income was -$26.97 M.
See VolitionRx Limited,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$1.23 M |
$775.30 K |
$306.39 K |
$90.04 K |
$13.43 K |
$17.10 K |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$639.92 K
|
$542.48 K
|
$309.41 K
|
$0.00
|
| Gross Profit |
$1.23 M
|
$775.30 K
|
$306.39 K
|
$90.04 K
|
$13.43 K
|
$17.10 K
|
-$639.92 K
|
-$542.48 K
|
-$309.41 K
|
$0.00
|
| Gross Profit Ratio |
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$14.41 M
|
$19.55 M
|
$15.33 M
|
$13.02 M
|
$14.53 M
|
$10.36 M
|
$10.91 M
|
$8.91 M
|
$6.84 M
|
$6.10 M
|
| General & Administrative Expenses |
$12.72 M
|
$15.91 M
|
$15.35 M
|
$14.08 M
|
$5.47 M
|
$4.52 M
|
$5.78 M
|
$5.36 M
|
$5.43 M
|
$3.90 M
|
| Selling & Marketing Expenses |
$922.60 K
|
$1.01 M
|
$1.05 M
|
$746.11 K
|
$1.07 M
|
$965.71 K
|
$1.17 M
|
$763.41 K
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$13.64 M
|
$16.92 M
|
$16.40 M
|
$14.83 M
|
$6.54 M
|
$5.49 M
|
$6.95 M
|
$6.13 M
|
$5.43 M
|
$3.90 M
|
| Other Expenses |
$212.43 K
|
$292.05 K
|
$348.81 K
|
$574.39 K
|
$187.83 K
|
$211.73 K
|
$37.23 K
|
$349.84 K
|
-$361.33 K
|
-$15.68 K
|
| Operating Expenses |
$28.26 M
|
$36.76 M
|
$32.09 M
|
$28.42 M
|
$21.26 M
|
$16.06 M
|
$17.90 M
|
$15.05 M
|
$11.91 M
|
$9.86 M
|
| Cost And Expenses |
$28.26 M
|
$36.76 M
|
$32.09 M
|
$28.42 M
|
$21.26 M
|
$16.06 M
|
$17.90 M
|
$15.05 M
|
$11.91 M
|
$9.86 M
|
| Interest Income |
$9.95 K
|
$93.32 K
|
$125.27 K
|
$2.73 K
|
$49.50 K
|
$112.37 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$340.36 K
|
$221.62 K
|
$173.09 K
|
$155.80 K
|
$129.80 K
|
$126.57 K
|
$110.92 K
|
$73.13 K
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$1.34 M
|
$1.41 M
|
$1.19 M
|
$1.15 M
|
$1.04 M
|
$902.41 K
|
$639.92 K
|
$542.48 K
|
$309.41 K
|
$236.34 K
|
| EBITDA |
-$25.58 M |
-$34.04 M |
-$29.24 M |
-$25.69 M |
-$19.23 M |
-$15.07 M |
-$17.26 M |
-$14.15 M |
-$11.60 M |
-$9.96 M |
| EBITDA Ratio |
-20.74
|
-43.91
|
-95.42
|
-285.32
|
-1431.41
|
-881.5
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-21.91
|
-46.42
|
-103.72
|
-314.69
|
-1581.76
|
-938.4
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$233.02 K
|
$310.62 K
|
$1.18 M
|
$1.34 M
|
$848.52 K
|
-$56.13 K
|
-$110.92 K
|
-$73.13 K
|
$361.33 K
|
$470.87 K
|
| Income Before Tax |
-$27.26 M
|
-$35.68 M
|
-$30.60 M
|
-$26.99 M
|
-$20.40 M
|
-$16.10 M
|
-$18.01 M
|
-$14.77 M
|
-$11.91 M
|
-$9.53 M
|
| Income Before Tax Ratio |
-22.1
|
-46.02
|
-99.87
|
-299.77
|
-1518.6
|
-941.69
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$110.92 K
|
-$276.71 K
|
$0.00
|
-$4.60 K
|
| Net Income |
-$26.97 M
|
-$35.32 M
|
-$30.27 M
|
-$26.81 M
|
-$20.35 M
|
-$16.10 M
|
-$18.01 M
|
-$14.77 M
|
-$11.91 M
|
-$9.53 M
|
| Net Income Ratio |
-21.86
|
-45.56
|
-98.79
|
-297.82
|
-1515.08
|
-941.69
|
0
|
0
|
0
|
0
|
| EPS |
-0.31 |
-0.5 |
-0.55 |
-0.51 |
-0.45 |
-0.41 |
-0.57 |
-0.56 |
-0.52 |
-0.54 |
| EPS Diluted |
-0.31 |
-0.5 |
-0.55 |
-0.51 |
-0.45 |
-0.41 |
-0.57 |
-0.56 |
-0.52 |
-0.54 |
| Weighted Average Shares Out |
$86.53 M
|
$71.23 M
|
$55.35 M
|
$52.66 M
|
$45.28 M
|
$39.18 M
|
$31.39 M
|
$26.39 M
|
$23.05 M
|
$17.73 M
|
| Weighted Average Shares Out Diluted |
$86.53 M
|
$71.23 M
|
$55.35 M
|
$52.66 M
|
$45.28 M
|
$39.18 M
|
$31.39 M
|
$26.39 M
|
$23.05 M
|
$17.73 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
